Search
BioPharma Dive
- Pascal Kraft
- Jun 14, 2022
- 1 min read
Ymmunobio Signs Collaboration Agreement with YUMAB
Ymmunobio get ownership rights to NPTXR antibodies. Read more here: https://www.drugdiscoverytrends.com/ymmunobio-gets-ownership-rights-t...
Michel Janicot will serve in the newly created position of chief development officer. https://www.fiercebiotech.com/biotech/chutes-ladder...
Comments